Stock info Ligand Pharmaceuticals Inc | Filter  Basic-Info

Stock: Ligand Pharmaceuticals Inc (US broad)

Last Price 208.16 Max Price 209.29
Min Price 96.67 1 Year return 157.82
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Country: USAWebsite: www.ligand.com

Sector Review Ligand Pharmaceuticals Inc

Loading...
Year Turnover Total sector Market share
2019 107 136,070 0.08 %
2020 153 153,065 0.10 %
2021 244 227,669 0.11 %
2022 183 260,393 0.07 %
2023 119 215,054 0.06 %

Advice Ligand Pharmaceuticals Inc

No Records Found




News Ligand Pharmaceuticals Inc

No Records Found

Annual reports Ligand Pharmaceuticals Inc

No Records Found


Profile Ligand Pharmaceuticals Inc

Ligand Pharmaceuticals Inc


The past year was a good investment year for Ligand Pharmaceuticals Inc investors

Over the last 12 months, that were loss-making period for the investors in Ligand Pharmaceuticals Inc, the stock lost around 1 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 834 percent. Ligand Pharmaceuticals Inc's revenues between 2011 and 2015 were very volatile through the time and moved between 31,39 million dollars and 71,91 million dollars. Ligand Pharmaceuticals Inc's net results between 2011 and 2015 were very fluctuating and moved between 9,71 million dollars and 254,93 million dollars.

The company mostly operates in the pharmaceutical sector. The global pharmaceutical companies gained over the past 10 years on average 75 percent. Since 2011 the sector is 147 percent higher and over the past year minus 75 percent.

Over the past 5 years the American company paid out dividends. In the period 2011 till 2015 Ligand Pharmaceuticals Inc paid it's investors each year a higher dividend per share. Based on the raising dividend payments Ligand Pharmaceuticals Inc can be seen as a kind of dividend aristocrat.

Ligand Pharmaceuticals Inc' balance mostly financed with equity

At the end of 2015 the pharmaceutical company's balance sheet was worth 533,93 million dollars. Of the total balance sheet 229,54 million dollars (42,99 percent) was financed by debt. As per the end of 2015 Ligand Pharmaceuticals Inc's price/earnings-ratio equaled 4. So investors paid for 1 stock 4 times the earnings per share of 2015. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the pharmaceutical company's market size (her number of outstanding share times the stock price) equaled around 2,1 billion dollars. At the end of 2015 the American company had around 19,79 million stocks listed on the exchanges.

All Ligand Pharmaceuticals Inc's annual reports can be found here. More information about Ligand Pharmaceuticals Inc can be found it's website. .


Results Ligand Pharmaceuticals Inc

Results
2021
2022
2023
2024
2025
Revenue
Costs
Profit
Margin of profit
ROI

Balance Ligand Pharmaceuticals Inc

Balance
2021
2022
2023
2024
2025
Equity
Debt
Total assets
Solvency
Cash
Cashflow
Employees
Revenue per employee
Cashflow / Debt

Details Ligand Pharmaceuticals Inc

Details
2016
2017
2018
2019
2020
Price
63.36
85.38
84.62
65.03
62.01
Eps
-0.07
0.45
5.19
28.41
-0.15
Price/earnings-ratio
-905.14
189.73
16.30
2.29
-1387.73
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
15.53
15.76
23.55
40.68
36.13
Market to book
0.25
0.18
0.28
0.63
0.17
Cashflow per stock
2.76
3.49
8.15
-1.56
2.78
Stocks
21
21
21
17
16
Market Cap
1.324.81
1.805.67
1.757.18
1.094.00
3.347.21

Dividend Ligand Pharmaceuticals Inc


Price info Ligand Pharmaceuticals Inc

Date
Price
10 Mar 2026
208.16
08 Mar 2026
201.90
03 Mar 2026
202.55
24 Feb 2026
183.65
10 Feb 2026
186.93
06 Feb 2026
191.69
04 Feb 2026
198.84
28 Jan 2026
195.49
26 Jan 2026
201.15
21 Jan 2026
196.56
17 Jan 2026
192.97
13 Jan 2026
206.81
21 Dec 2025
200.33
18 Dec 2025
194.59
17 Dec 2025
192.63
16 Dec 2025
192.88
15 Dec 2025
189.55
11 Dec 2025
184.03
10 Dec 2025
185.83
09 Dec 2025
184.67
04 Dec 2025
193.03
03 Dec 2025
195.10
27 Nov 2025
206.16
26 Nov 2025
203.52
22 Nov 2025
199.23
20 Nov 2025
206.05
19 Nov 2025
207.05
18 Nov 2025
201.35
17 Nov 2025
200.86
15 Nov 2025
200.86